ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0897

Dynamic eQTLs from Activated Human B Cells Suggest Cell-state Dependent Effects for GWAS Risk Variants in BLK

Yao Fu, David Murphy, Richard Pelikan, Jeniffer Kelly, Kiely Grundahl, Satish Pasula, Kandice Tessneer and Patrick Gaffney, Oklahoma Medical Research Foundation, Oklahoma City, OK

Meeting: ACR Convergence 2024

Keywords: B-Lymphocyte, Bioinformatics, Epigenetics, genetics, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Genetics, Genomics & Proteomics Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic lupus erythematosus (SLE) is a complex genetic disease in which B cells play a critical role in pathogenesis. Previous genome-wide association studies (GWAS) have identified many SLE risk loci and genes important for B cell function. However, it is still unclear how the causal variants within these associations translate to the dysregulated molecular mechanisms that drive the disease. Identifying and characterizing dynamic eQTL effects specifically in primary B cell subtypes treated with an SLE-like inflammatory stimulus using single-cell RNA sequencing (scRNA-seq) may offer new insights into variant-to-function relationships.

Methods: Primary B cells were isolated from 19 healthy donors of Northern European ancestry, then split and cultured for 48 hours with or without a physiologically relevant, defined B cell stimulation to model human SLE: B cell receptor crosslinking IgM/G Fab fragment, CD40 ligand, and TLR7 agonist R837. After 48 hours of culture, the cells were collected and subjected to genotyping and scRNA-seq. The Poisson Mixed Effect (PME) modeling was applied to identify dynamic eQTLs. First, Harmony was used with 10 principal components (PCs) to remove sample- and treatment-specific effects. Each PC was calculated as an independent, continuous, and dynamic cell state covariate. Candidate eQTLs were then fitted with the PME model to test interactions of genotype effects with multiple covariates (donor fixed effects: age, sex, and genotype PCs; cell fixed effects: gene expression PCs, percent mitochondrial UMIs, and number of UMIs; random effects: donor and batch).

Results: B cell size and viability were significantly increased in response to stimulation. Cell surface CD86 expression also increased, confirming the efficacy of the stimulation. A total of 186,240 B cells (76,230 resting and 110,010 stimulated) were recovered in scRNA-seq. Eight B cell subtypes were manually assigned according to the marker genes of each cluster: transitional cells, naïve resting, naïve activated, memory unswitched, memory switched resting, memory switched activated, plasmablasts, and plasma cells. Three B cell subsets were significantly increased after stimulation: plasmablasts (69.7-fold), naïve activated cells (7.9-fold), and plasma cells (3.6-fold) (Table 1). From an input of 1,353 most significant eQTLs identified in our previous bulk RNA-seq data, we identified 254 eQTLs that demonstrated a significant interaction between genotype and cell state (likelihood ratio-test, FDR < 0.05). For example, two BLK eQTL variants positioned on the same haplotype (rs1478898 and rs2061830) demonstrated dynamic eQTL effects across B cell subsets but opposing responses to stimulation.

Conclusion: scRNA-seq revealed B cell subtype-specific dynamic eQTL effects in response to stimulation. The PME analysis was able to identify dynamic eQTLs, whose genotype effects are dependent on continuous cell states, and characterize the unique genotype effects at single-cell resolution without the limitations of common pseudobulk approaches. We are currently expanding this dataset with 40 more samples to increase power.

Supporting image 1

Table 1: Total cells from the stimulated samples were adjusted downward by randomly sampling cells until a total adjusted cell count equal to that of the resting cells was reached. The red box highlights cell subsets expanded in stimulated samples.


Disclosures: Y. Fu: None; D. Murphy: None; R. Pelikan: None; J. Kelly: None; K. Grundahl: None; S. Pasula: None; K. Tessneer: None; P. Gaffney: None.

To cite this abstract in AMA style:

Fu Y, Murphy D, Pelikan R, Kelly J, Grundahl K, Pasula S, Tessneer K, Gaffney P. Dynamic eQTLs from Activated Human B Cells Suggest Cell-state Dependent Effects for GWAS Risk Variants in BLK [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/dynamic-eqtls-from-activated-human-b-cells-suggest-cell-state-dependent-effects-for-gwas-risk-variants-in-blk/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dynamic-eqtls-from-activated-human-b-cells-suggest-cell-state-dependent-effects-for-gwas-risk-variants-in-blk/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology